Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc > AGN Share Price will Need to be at $1.00

<< Previous

Bullboard Posts

Next >>

Comment by fruiscante1on Mar 10, 2021 9:27am

79 Views

Post# 32761412

RE:RE:AGN Share Price will Need to be at $1.00

I believe they are assuming that all warrants an options would get excercised at that point, which is the most likely scenario. Share price guessing games aren't usually worth the time in my opinion, but have atter if ya like, not much else to do but wait these days, lol.

<< Previous

Bullboard Posts

Next >>

One of the strongest contenders to lead Canada’s cannabis market